{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:05:59Z","timestamp":1785535559911,"version":"3.56.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To analyze the mutational spectrum, clinical characteristics, genotype\u2013phenotype correlations, testicular adrenal rests tumor prevalence, and role of neonatal screening in congenital adrenal hyperplasia (CAH) patients from Slovakia and Slovenia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and methods<\/jats:title><jats:p>Data were obtained from 104 patients with CAH registered in Slovak and Slovenian databases. Low-resolution genotyping was performed to detect the most common point mutations. To detect deletions, conversions, point mutations, or other sequence changes in the <jats:italic>CYP21A2<\/jats:italic> gene, high-resolution genotyping was performed. Genotypes were classified according to residual 21-hydroxylase activity (null, A, B, C).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>64% of the individuals had the salt-wasting form (SW-CAH), 15% the simple virilizing form (SV-CAH), and 21% the non-classic (NC-CAH). <jats:italic>CYP21A2<\/jats:italic> gene deletion\/conversion and c.293-13A\/C&amp;gt;G pathogenic variant accounted together for 55.5% of the affected alleles. In SV-CAH p.Ile172Asn was the most common pathogenic variant (28.13%), while in NC-CAH p.Val282Leu (33.33%), <jats:italic>CYP21A2<\/jats:italic> gene deletion\/conversion (21.43%), c.293-13A\/C&amp;gt;G (14.29%), Pro30Leu (11.90%). The frequency of alleles with multiple pathogenic variants was higher in Slovenian patients (15.83% of all alleles). Severe genotypes (0 and A) correlated well with the expected phenotype (SW in 94.74% and 97.3%), while less severe genotypes (B and C) correlated weaklier (SV in 50% and NC in 70.8%). The median age of SW-CAH patients at the time of diagnosis was 6 days in Slovakia vs. 28.5 days in Slovenia (p=0.01). Most of the Slovak patients in the cohort were detected by NBS. (24 out of 29). TARTs were identified in 7 out of 24 male patients, of whom all (100%) had SW-CAH and all had poor hormonal control. The median age at the diagnosis of TARTs was 13 years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The study confirmed the importance of neonatal screening, especially in the speed of diagnosis of severe forms of CAH. The prediction of the 21-OH deficiency phenotype was reasonably good in the case of severe pathogenic variants, but less reliable in the case of milder pathogenic variants, which is consistent compared to data from other populations. Screening for TARTs should be realized in all male patients with CAH, since there is possible remission when identified early.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1134133","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T13:52:09Z","timestamp":1679061129000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Genetic and clinical characteristics including occurrence of testicular adrenal rest tumors in Slovak and Slovenian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency"],"prefix":"10.3389","volume":"14","author":[{"given":"Robert","family":"Saho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vita","family":"Dolzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojca","family":"Zerjav Tansek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pastorakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Knapkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Trebusak Podkrajsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasna","family":"Suput Omladic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bertok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Avbelj Stefanija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Primoz","family":"Kotnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadej","family":"Battelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Pribilincova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urh","family":"Groselj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.21.3.0398","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"21","author":"White","year":"2000","journal-title":"Endocr Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1210\/endrev\/bnab016","article-title":"Congenital adrenal hyperplasia-current insights in pathophysiology, diagnostics, and management","volume":"43","author":"Claahsen-van der Grinten","year":"2022","journal-title":"Endocr Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1530\/EC-18-0281","article-title":"Genotype\/phenotype correlations in 538 congenital adrenal hyperplasia patients from Germany and Austria: Discordances in milder genotypes and in screened versus prescreening patients","volume":"8","author":"Riedl","year":"2019","journal-title":"Endocr connections"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1300057110","article-title":"Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency","volume":"110","author":"New","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04123.x","article-title":"Steroid 21-hydroxylase gene mutational spectrum in 454 argentinean patients: Genotype-phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia","volume":"75","author":"Marino","year":"2011","journal-title":"Clin Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021681","article-title":"CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in the Netherlands: Six novel mutations and a specific cluster of four mutations","volume":"88","author":"Stikkelbroeck","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1530\/eje.1.01944","article-title":"Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in middle European patients with congenital adrenal hyperplasia","volume":"153","author":"Dolzan","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0171","article-title":"Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction","volume":"175","author":"de Carvalho","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-022-00348-z","article-title":"Molecular analysis and genotype-phenotype correlations in patients with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency from southern Poland - experience of a clinical center","volume":"21","author":"Kurzy\u0144ska","year":"2022","journal-title":"Hormones (Athens)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jsbmb.2016.06.015","article-title":"Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia","volume":"165","author":"Parsa","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijns7010011","article-title":"Newborn screening for CAH-challenges and opportunities","volume":"7","author":"Heather","year":"2021","journal-title":"Int J Neonatal Screen"},{"key":"B12","article-title":"Molekulovo genetick\u00e1 podstata a diagnostika kongenit\u00e1lnej adren\u00e1lnej hyperpl\u00e1zie na slovensku","volume":"2020","author":"Pastor\u00e1kov\u00e1","year":"2020","journal-title":"Lek\u00e1rsky obzor"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00258","article-title":"Testicular adrenal rest tumors: Current insights on prevalence, characteristics, origin, and treatment","volume":"40","author":"Engels","year":"2019","journal-title":"Endocr Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4008\/jcrpe.v1i3.49","article-title":"CYP21A2 gene mutations in congenital adrenal hyperplasia: Genotype-phenotype correlation in Turkish children","volume":"1","author":"Ba\u015f","year":"2009","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1410132","article-title":"Adrenal 21-hydroxylase gene mutations in Slovenian hyperandrogenic women: Evaluation of corticotrophin stimulation and HLA polymorphisms in screening for carrier status","volume":"141","author":"Dolzan","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2008.10.014","article-title":"Genetics of congenital adrenal hyperplasia. Best practice & research","volume":"23","author":"Krone","year":"2009","journal-title":"Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s004390050672","article-title":"Molecular genetic analysis of patients carrying steroid 21-hydroxylase deficiency in the Mexican population: Identification of possible new mutations and high prevalence of apparent germ-line mutations","volume":"102","author":"Ordo\u00f1ez-S\u00e1nchez","year":"1998","journal-title":"Hum Genet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1987.tb02414.x","article-title":"Molecular characterization of the HLA-linked steroid 21-hydroxylase b gene from an individual with congenital adrenal hyperplasia","volume":"6","author":"Rodrigues","year":"1987","journal-title":"EMBO J"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s004390050394","article-title":"Mutation-haplotype analysis of steroid 21-hydroxylase (CYP21) deficiency in finland. implications for the population history of defective alleles","volume":"99","author":"Levo","year":"1997","journal-title":"Hum Genet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S2213-8587(13)70007-X","article-title":"One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study","volume":"1","author":"Gidl\u00f6f","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2001-011939","article-title":"Three novel mutations in CYP21 gene in Brazilian patients with the classical form of 21-hydroxylase deficiency due to a founder effect","volume":"87","author":"Billerbeck","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2594","article-title":"Inhibition of CYP21A2 enzyme activity caused by novel missense mutations identified in Brazilian and Scandinavian patients","volume":"93","author":"Soardi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0319","article-title":"Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"96","author":"Finkielstain","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.steroids.2016.01.007","article-title":"21-hydroxylase deficiency-induced congenital adrenal hyperplasia in 230 Chinese patients: Genotype-phenotype correlation and identification of nine novel mutations","volume":"108","author":"Wang","year":"2016","journal-title":"Steroids"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2009.01.001","article-title":"The gene founder effect of two spontaneous mutations in ethnic Chinese (Taiwanese) CAH patients with 21-hydroxylase deficiency","volume":"97","author":"Lee","year":"2009","journal-title":"Mol Genet Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115897","article-title":"Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"90","author":"Speiser","year":"1992","journal-title":"J Clin Invest"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.17344\/acsi.2015.1797","article-title":"Clinical role of CYP2C19 polymorphisms in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"63","author":"Gro\u0161elj","year":"2016","journal-title":"Acta Chimica Slovenica."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.10.7898","article-title":"Mutational spectrum of the steroid 21-hydroxylase gene in Austria: identification of a novel missense mutation","volume":"86","author":"Baumgartner-Parzer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1042\/bj3160325","article-title":"Function and membrane topology of wild-type and mutated cytochrome p-450c21","volume":"316","author":"Hu","year":"1996","journal-title":"Biochem J"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)45304-X","article-title":"Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus","volume":"265","author":"Tusie-Luna","year":"1990","journal-title":"J Biol Chem"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)39804-7","article-title":"A missense mutation at Ile172\u2013-Asn or Arg356\u2013-Trp causes 21-hydroxylase deficiency","volume":"265","author":"Chiou","year":"1990","journal-title":"J Biol Chem"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0201","article-title":"Prevalence of testicular adrenal rest tumours in male children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"157","author":"Claahsen-van der Grinten","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12033","article-title":"Prevalence and long-term follow-up outcomes of testicular adrenal rest tumours in children and adolescent males with congenital adrenal hyperplasia","volume":"78","author":"Aycan","year":"2013","journal-title":"Clin Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0097","article-title":"Testicular adrenal rest tumors in boys with 21-hydroxylase deficiency, timely diagnosis and follow-up","volume":"7","author":"Kocova","year":"2018","journal-title":"Endocr Connections."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.21037\/tau-20-998","article-title":"Prevalence and ultrasound patterns of testicular adrenal rest tumors in adults with congenital adrenal hyperplasia","volume":"10","author":"Corcioni","year":"2021","journal-title":"Trans Androl Urol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0828","article-title":"Fertility, sexuality and testicular adrenal rest tumors in adults males with congenital adrenal hyperplasia","volume":"166","author":"Falhammar","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.12.8090","article-title":"High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia","volume":"86","author":"Stikkelbroeck","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2022.104654","article-title":"Genotype of congenital adrenal hyperplasia patients with testicular adrenal rest tumor","volume":"65","author":"Aycan","year":"2022","journal-title":"Eur J Med Genet"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1134133\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T13:52:12Z","timestamp":1679061132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1134133\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":38,"alternative-id":["10.3389\/fendo.2023.1134133"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1134133","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"article-number":"1134133"}}